THE OUTLOOK FOR HEALTH CARE IN 2023:

What you need to know about the forces reshaping our industry.

X

Recommended reading

Lung cancer detection

Sponsored by The Lung Ambition Alliance

Blog: Nearly twice as many patients are now eligible for lung cancer screenings—here is what you need to know

Read the blog
Blog: The opportunity to reduce lung cancer mortality and disparities hidden in plain sight

Read the blog
Case study: How Carle Health advances early lung cancer detection through incidental findings

Download the slides
Case study: How Wellstar built a truly patient-centric early lung cancer detection program

Download the case study
Webinar: Strategies to build and grow a comprehensive lung cancer detection program

Watch the recording and download the slides
Webinar: Why and how to address health disparities in lung cancer detection

Learn more
Webinar: How to advance early lung cancer detection with incidental findings

Watch the recording and download the slides

About the sponsor

The Lung Ambition Alliance, a global coalition with partners across disciplines in over 50 countries, was formed to combat lung cancer through accelerating innovation and driving forward meaningful improvements for people with lung cancer. We do this by advocating for improved approaches in three areas: screening and early diagnosis, accelerated delivery of innovative medicine, and improved quality care.

Learn more about The Lung Ambition Alliance

This report is sponsored by AstraZeneca, an Advisory Board member organization. Representatives of AstraZeneca helped select the topics and issues addressed. Advisory Board experts wrote the report, maintained final editorial approval, and conducted the underlying research independently and objectively. Advisory Board does not endorse any company, organization, product or brand mentioned herein.

To learn more, view our editorial guidelines

Have a Question?

x

Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.